HIV resistance to the antiretroviral drug tenofovir (Viread) is increasingly common, a new study finds.
The researchers said their finding is surprising and alarming because the drug plays a major role in treating and preventing infection with HIV, the virus that causes AIDS.
“Tenofovir is a critical part of our armamentarium against HIV, so it is extremely concerning to see such a high level of resistance to this drug,” study
